The Potential of Genotyping

This publication has 7 references indexed in Scilit:

• The Crucial Role of the Therapeutic Window in Understanding the Clinical Relevance of the Poor Versus the Ultrarapid Metabolizer Phenotypes in Subjects Taking Drugs Metabolized by CYP2D6 or CYP2C19
  Journal of Clinical Psychopharmacology, 2007
• A Study of Genetic (CYP2D6 and ABCB1) and Environmental (Drug Inhibitors and Inducers) Variables That May Influence Plasma Risperidone Levels
  Pharmacopsychiatry, 2007
• A Poor Metabolizer for Cytochromes P450 2D6 and 2C19: A Case Report on Antidepressant Treatment
  CNS Spectrums, 2006
• Clinical Guidelines for Psychiatrists for the Use of Pharmacogenetic Testing for CYP450 2D6 and CYP450 2C19
  Psychosomatics, 2006
• Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
  Molecular Psychiatry, 2004
• Problems in the “Evidence” of “Evidence-Based Medicine”
  The American Journal of Medicine, 1997
• Evidence based medicine and ethics.
  Journal of Medical Ethics, 1995